Zimmer Wins Genzyme Patent Trial Over Knee-Arthritis Treatment
3 the Gel-One product made by Tokyo-based Seikagaku and distributed by Zimmer doesn't infringe a Genzyme patent for a method to treat arthritic pain in the knee. The jury also said that the patent is invalid because it covered obvious variations of …
Full News here – Read more on Bloomberg










